Genomics and Microbiome Investigation in Cases of Recurrent Pregnancy Losses
Evaluation of Predisposing Factors for Idiopathic Recurrent Pregnancy Losses: a Study Using a Genomic and Microbiota Approach
2 other identifiers
observational
20
1 country
1
Brief Summary
Recurrent pregnancy losses (RPL) are characterized by the occurrence of more than one spontaneous pregnancy loss. It is caused by different known factors, but about half of the cases remain without an explanation. Efforts are being done in the scientific community to solve this cases. In this study, the investigators aim to investigate genetic factors that might predispose to RPL, as well as the influence of the uterine microbiota (microorganisms that normally live in the uterus of women).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2024
CompletedFirst Submitted
Initial submission to the registry
September 9, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedSeptember 19, 2024
September 1, 2024
1.2 years
September 9, 2024
September 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Microbiome
The participants microbiome will be evaluated aiming to compare the species profile between cases and controls. The bacteria present in the microbiome will be described at the genus and species level.
At the time of enrollment
Exome
The participants exomes will be evaluated to look for variants in specific genes, aiming to identify rare variants that will be compared with frequencies from population genomic databases. The impact of the identified variants on proteins will be assessed through in silico functional predictors.
At the time of enrollment
Study Arms (2)
RPL group
The RPL group will include women with a history of at least two spontaneous pregnancy losses, regardless of whether they have living children, and whose etiology for the pregnancy losses was not determined by the care team's protocols.
Control group
Women with at least two full-term pregnancies and no history of difficulty getting pregnant, pregnancy loss or other infertility factors will be enrolled in the control group.
Interventions
A cervical microbiota analysis will be performed in the RPL and control groups.
Eligibility Criteria
Women who seek the Gynecology and Obstetrics Service of the Hospital de Clínicas de Porto Alegre (HCPA) for care and investigation of causes of infertility or for exams not related to this condition will be included in the study.
You may qualify if:
- RPL group: history of at least two spontaneous pregnancy losses, regardless of whether they have living children, and whose etiology for the pregnancy losses was not determined by the care team\'s protocols;
- Control group: at least two full-term pregnancies and no history of difficulty getting pregnant, pregnancy loss or other infertility factors.
You may not qualify if:
- RPL group: less than two spontaneous pregnancy losses and those with a known cause for repeated pregnancy losses;
- Control group: N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital de Clínicas de Porto Alegre (HCPA)
Porto Alegre, Rio Grande do Sul, 90410-000, Brazil
Biospecimen
Peripheral blood and cervical samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lucas Rosa Fraga, PhD, Professor
Hospital de Clínicas de Porto Alegre
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2024
First Posted
September 19, 2024
Study Start
April 14, 2023
Primary Completion
July 5, 2024
Study Completion
December 1, 2025
Last Updated
September 19, 2024
Record last verified: 2024-09